In this work, CRC cell-specific restoration of purified recombinant p53 protein was accomplished via the use of p28 for delivery, a CPP that also inhibits the E3 ubiquitin ligase COP1, and a de novo-designed CEABP1 protein module for targeting. The gene discussed is TP53; the disease is colorectal carcinoma.